Figaroa, O. J. A.
Spaanderman, I. T.
Goedegebuure, R. S. A.
Cirkel, G. M.
Jeurissen, F. J. F.
Creemers, G. J.
Bins, A. D.
Tuynman, J.
Buffart, T. E.
Funding for this research was provided by:
kwf
Article History
Received: 17 December 2024
Revised: 5 June 2025
Accepted: 27 July 2025
First Online: 22 September 2025
Competing interests
: The authors declare no competing interests.
: All patients signed the informed consent form, either through the ATAPEMBRO trial (NCT04014530) or under the approval of the institutional review board (IRB) of the Amsterdam UMC (IRB00013752). All methods were performed in accordance with the relevant guidelines and regulations.